Please select the option that best describes you:

What are your institutions' preferences on SBRT vs. histotripsy for treatment of liver metastases?   

Are you aware of any data to support one modality over the other? 



Answer from: Radiation Oncologist at Community Practice
Comments
Radiation Oncologist at Sarah Cannon Research Institute
Well said. Let's hope it doesn't take 4 decades to...
Sign in or Register to read more